Cargando…
Comparison of the efficacy of liraglutide with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycaemia in albino rats
OBJECTIVES: To evaluate the efficacy of liraglutide with pioglitazone for prevention of dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycemia in Albino rats. MATERIALS AND METHODS: There were four groups of six rats each. First group received dexamethasone alone in a dose of 8 mg/k...
Autores principales: | Vinodraj, K., Nagendra Nayak, I. M., Rao, J. Vikram, Mathai, Paul, Chandralekha, N., Nitasha, B., Rajesh, D., Chethan, T. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386127/ https://www.ncbi.nlm.nih.gov/pubmed/25878378 http://dx.doi.org/10.4103/0253-7613.153426 |
Ejemplares similares
-
Comparison of the efficacy of cardamom (Elettaria cardamomum) with pioglitazone on dexamethasone-induced hepatic steatosis, dyslipidemia, and hyperglycemia in albino rats
por: Nitasha Bhat, G. M., et al.
Publicado: (2015) -
Dexamethasone: Sinonasal mucormycosis and hyperglycaemia: case report
Publicado: (2021) -
Dexamethasone: Hyperglycaemia and adrenal insufficiency: 2 case reports
Publicado: (2021) -
Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia
por: Rhou, Yoon Ji J, et al.
Publicado: (2022) -
Dexamethasone: Hyperglycaemia following off-label use: case report
Publicado: (2022)